CN丨 EN

Welcome to Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.！

Home丨 Contact Us

Search
Register

Copyright:  Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.！   京ICP备19006400号-1​     Powered by 300.cn

About Us
Company Overview
Advisors
Qualifications
Memorabilia
Technology
Technology Platform
Products
Intellectual Property
Clinical Programs
Cooperative Partners
Clinical Indications
Clinical Cases
Science
Stem Cells
Stem Cell-Derived Exosomes
Stem Cell Factors
News Center
Company News
Press Release
Contact Us
Contact Us
Videos
Download Center
Online Message

美科

Jiuzhitang丨 Mudanjiang Youbo Pharmaceutical 丨 Beijing Tiantan Hospital丨 No.1 Hospital-Harbin Medical Sciences University丨 Stemedica丨

Links：

China’s first clinical trial treating ischemic stroke with an imported stem cell product was formally launched.

Source:
Release time：
2021/01/12 14:14
Page view

China’s first clinical trial treating ischemic stroke with an imported stem cell product was formally launched. 

Previous article:
Jiuzhitang Maker received fund support from Daxing District Program for Advancing Transfer and Transformation of Technological Achievements.
Jiuzhitang Maker was awarded the prize of "Excellent Enterprise Assuming Social Responsibilities in 2020" by Health News.
Next article: